batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Jazz joins the KRAS band with Redx deal 7 February 2024 Gilead deals more checkpoint disappointment 7 February 2024 The pullback from RET inhibition 6 February 2024 Bristol shows its alnuctamab hand 5 February 2024 Bicycle rides onto its accelerated pathway 31 January 2024 ASCO-GU – subcutaneous Opdivo puts the pressure on Merck 30 January 2024 Roche walks away from Hookipa’s KRAS immunotherapy 29 January 2024 Kura’s PIPE dream 25 January 2024 Load More